Keck Graduate Institute | GenomeWeb

Keck Graduate Institute

The test detects a signature molecular marker upregulated by viable bacteria, and will be useful for pediatric, extrapulmonary, and AIDS-related TB.

Claremont BioSolutions has been awarded a three-year, $3 million grant from the National Institute of Allergy and Infectious Diseases to continue developing its fully integrated and portable point-of-care assay system for detecting Clostridium difficile infections and co

Scientists from the Keck Graduate Institute of Applied Life Sciences and KGI spinout Claremont Biosolutions have been developing point-of-care molecular testing platforms and associated assays for Clostridium difficile, multi-drug-resistant tuberculosis, and herpes simpl

Steven Casper, director of the master of bioscience degree program at the Keck Graduate Institute of Applied Life Sciences, discusses a recent report assessing the Los Angeles region's life sciences strengths and shortcomings.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.